In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
about
A focus on intra-abdominal infections.In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis.In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenemIn vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems.In vivo activities of peptidic prodrugs of novel aminomethyl tetrahydrofuranyl-1 beta-methylcarbapenems.In vivo pharmacodynamic activity of tomopenem (formerly CS-023) against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models.Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological AgeDoripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.In vitro antimicrobial activity of doripenem, a new carbapenemUrinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis.Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities.Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections.Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.Pharmacodynamics of the antibacterial effect of and emergence of resistance to doripenem in Pseudomonas aeruginosa and Acinetobacter baumannii in an in vitro pharmacokinetic model.In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.Activities of doripenem (S-4661) against drug-resistant clinical pathogens.Characteristics of doripenem: a new broad-spectrum antibiotic.In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
P2860
Q33763449-D85C4982-ACB8-4A93-9196-5CEAC6595244Q33836698-6B655335-FA01-4644-B95B-2A0ACDEC76E1Q33938036-77F72202-1FCC-4D91-827C-D0478036AC0BQ33976352-D6A934FF-441B-4D7C-9E80-89C02F1F9BE4Q33976359-3FE5A79C-06BD-41F1-924D-56F4FBA871A2Q34309420-22EEE7D1-F788-430A-AE2D-342B410CB186Q35007624-47CCD0DD-E923-489B-8CC9-1C9DD5D7322FQ35166038-756F1D6B-2DD8-4CA4-AC39-DDDAC14A426CQ35859870-865622F5-8746-4DC0-813D-FC4E9868BEE0Q36670323-D5AC1BB7-F676-49E6-B947-39ADA41C9099Q37120635-AC61A335-5677-4373-ACF9-06762370A425Q37121257-82E823FB-951D-4C83-8884-4B8B4020F260Q37144843-B14AA4E9-FFC6-4FDD-A270-8EE3FCA291D2Q37160369-124C946E-109C-487A-905A-BB84D85914A0Q38405565-CEDFF31A-6DB4-4291-8891-4695F7FDD04FQ39473401-6D01D4FD-1F80-4E0F-BC01-6A1501F638ABQ39599930-21D992AD-C188-4E18-A142-3E691128D72EQ40049619-D6A7E7C2-80E4-4CA2-BA34-0856E1FF37E0Q41269719-CA7E672A-A987-4C3E-B412-66E84CB388EEQ42049594-5DDDD96F-759C-455E-B032-DC3F9515C22EQ42112586-E72363DA-6864-4D31-AB20-D9049D588B4A
P2860
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
@en
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
@nl
type
label
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
@en
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
@nl
prefLabel
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
@en
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
@nl
P2093
P2860
P356
P1476
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem
@en
P2093
P2860
P356
10.1128/AAC.42.1.94
P407
P577
1998-01-01T00:00:00Z